Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?

Amgen (NASDAQ:AMGN) beat Wall Street's earnings estimate with its fourth-quarter results. But the big biotech's 2020 outlook underwhelmed. Amgen expects to deliver modest earnings growth and return to revenue growth, but it wasn't enough to impress investors.